Top News
Latest News
INSIGHTS
13 Oct 2025
Wearables and Biologics Push Care Beyond the ClinicRESEARCH
10 Oct 2025
A $900 Million Shot: Halozyme Targets Smoother Drug DeliveryINNOVATION
8 Oct 2025
Faster Shots for Cancer Care: Merck’s Keytruda Qlex DebutsINVESTMENT
22 Sep 2025
Evonik–Ethris Alliance Targets Next Leap in RNA Medicine
Can These Nanoparticles Outsmart Your Cells?
INNOVATION
22 Jun 2025
Wyss Institute’s nanoparticle system improves precision and safety in non-viral gene and mRNA therapies
INSIGHTS
13 Oct 2025
Wearables and Biologics Push Care Beyond the Clinic
US firms pioneer wearable and greener drug-delivery systems as biologics reshape patient care
RESEARCH
10 Oct 2025
A $900 Million Shot: Halozyme Targets Smoother Drug Delivery
Halozyme’s $900M Elektrofi deal aims to speed up and simplify injectable biologic treatments
INNOVATION
8 Oct 2025
Faster Shots for Cancer Care: Merck’s Keytruda Qlex Debuts
Merck’s subcutaneous Keytruda Qlex offers faster cancer dosing, though IV remains the mainstay for most patients.
INVESTMENT
22 Sep 2025
Evonik–Ethris Alliance Targets Next Leap in RNA Medicine
Alliance aims to improve RNA stability and scaling, with potential to ease storage demands and broaden access
INNOVATION
22 Jun 2025
Can These Nanoparticles Outsmart Your Cells?
Wyss Institute’s nanoparticle system improves precision and safety in non-viral gene and mRNA therapies
MARKET TRENDS
16 Jun 2025
Fast-Track Cancer Care: Injections Replace IV Drips
Sanofi and Bristol Myers embrace subcutaneous delivery as infusion-based therapies give way to quicker, patient-friendly alternatives
SUBSCRIBE FOR UPDATES
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.